Literature DB >> 21295144

Rainbow trout surviving infections of viral haemorrhagic septicemia virus (VHSV) show lasting antibodies to recombinant G protein fragments.

P Encinas1, E Gomez-Casado, N J Olesen, N Lorenzen, A Estepa, J M Coll.   

Abstract

Rainbow trout antibodies (Abs) binding to recombinant fragments (frgs) derived from the protein G of the viral haemorrhagic septicemia virus (VHSV)-07.71 strain, could be detected by ELISA (frg-ELISA) in sera from trout surviving laboratory-controlled infections. Abs were detected not only by using sera from trout infected with the homologous VHSV isolate but also with the VHSV-DK-201433 heterologous isolate, which had 13 amino acid changes. Sera from healthy trout and/or from trout surviving infectious haematopoietic necrosis virus (IHNV) infection, were used to calculate cut-off absorbances to differentiate negative from positive sera. Specific anti-VHSV Abs could then be detected by using any of the following frgs: frg11 (56-110), frg15 (65-250), frg16 (252-450) or G21-465. While high correlations were found among the ELISA values obtained with the different frgs, no correlations between any frg-ELISA and complement-dependent 50% plaque neutralization test (PNT) titres could be demonstrated. Between 4 and 10 weeks after VHSV infection, more trout sera were detected as positives by using heterologous frg-ELISA rather than homologous PNT. Furthermore, the percentage of positive sera detected by frg11-ELISA increased with time after infection to reach 100%, while those detected by complement-dependent PNT decreased to 29.4%, thus confirming that the lack of neutralizing Abs does not mean the lack of any anti-VHSV Abs in survivor trout sera. Preliminary results with sera from field samples suggest that further refinements of the frg-ELISA could allow detection of anti-VHSV trout Abs in natural outbreaks caused by different heterologous VHSV isolates. The homologous frg-ELISA method could be useful to follow G immunization attempts during vaccine development and/or to best understand the fish Ab response during VHSV infections. The viral frgs approach might also be used with other fish species and/or viruses.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21295144     DOI: 10.1016/j.fsi.2011.01.021

Source DB:  PubMed          Journal:  Fish Shellfish Immunol        ISSN: 1050-4648            Impact factor:   4.581


  6 in total

1.  Development and evaluation of a blocking enzyme-linked immunosorbent assay and virus neutralization assay to detect antibodies to viral hemorrhagic septicemia virus.

Authors:  Anna Wilson; Tony Goldberg; Susan Marcquenski; Wendy Olson; Frederick Goetz; Paul Hershberger; Lucas Hart; Kathy Toohey-Kurth
Journal:  Clin Vaccine Immunol       Date:  2014-01-15

2.  Antibody recognition of the glycoprotein g of viral haemorrhagic septicemia virus (VHSV) purified in large amounts from insect larvae.

Authors:  Paloma Encinas; Silvia Gomez-Sebastian; Maria Carmen Nunez; Eduardo Gomez-Casado; Jose M Escribano; Amparo Estepa; Julio Coll
Journal:  BMC Res Notes       Date:  2011-06-21

3.  Innate Multigene Family Memories Are Implicated in the Viral-Survivor Zebrafish Phenotype.

Authors:  Amparo Estepa; Julio Coll
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

4.  Vaccine Adjuvants in Fish Vaccines Make a Difference: Comparing Three Adjuvants (Montanide ISA763A Oil, CpG/Poly I:C Combo and VHSV Glycoprotein) Alone or in Combination Formulated with an Inactivated Whole Salmonid Alphavirus Antigen.

Authors:  Hanna L Thim; Stéphane Villoing; Marian McLoughlin; Karen Elina Christie; Søren Grove; Petter Frost; Jorunn B Jørgensen
Journal:  Vaccines (Basel)       Date:  2014-03-25

5.  Herpesvirus Infection Induces both Specific and Heterologous Antiviral Antibodies in Carp.

Authors:  Julio M Coll
Journal:  Front Immunol       Date:  2018-01-24       Impact factor: 7.561

6.  Protein Nanoparticles Made of Recombinant Viral Antigens: A Promising Biomaterial for Oral Delivery of Fish Prophylactics.

Authors:  Rosemary Thwaite; Jie Ji; Débora Torrealba; Julio Coll; Manel Sabés; Antonio Villaverde; Nerea Roher
Journal:  Front Immunol       Date:  2018-07-18       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.